Physician Knowledge & Attitudes Toward Managing CKD

医师知识

• 批准号: 7000173
• 负责人: Rubeen K Israni
• 金额: $ 8.67万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2007-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7000173
• 关键词: ACE inhibitors; age difference; antihypertensive agents; behavioral /social science research tag; belief; blood pressure; cardiovascular disorder risk; chronic renal failure; clinical research; diagnosis quality /standard; early diagnosis; experience; female; gender difference; health care personnel performance; human old age (65+); human subject; kidney disorder chemotherapy; kidney disorder diagnosis; male; patient care management; patient care personnel attitude; postdoctoral investigator; primary care physician; questionnaires

DESCRIPTION (provided by applicant): A growing body of evidence indicates that therapeutic interventions such as strict blood pressure control, use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) at earlier stages of chronic kidney disease are effective in slowing the progression of chronic kidney disease. However, it is widely believed that CKD is "under-diagnosed" and "under-treated" in the United States resulting in lost opportunities for prevention. Few studies have tried to assess the factors associated with poor recognition and treatment of CKD. In this study we will send a questionnaire to a random sample of primary care physicians from AMA Master File. These questionnaires will look at physician ability to recognize CKD in men and women of different age groups, their attitude towards blood pressure goals and use of ACE inhibitors and ARBs in patients with CKD and their beliefs about risk of cardiovascular disease in the setting of CKD. We will then analyze the data to derive physician characteristics i.e. year of graduation; that are associated with better ability to recognize CKD and attitudes towards managing patients with CKD that are in line with current literature and guidelines.

描述（由申请人提供）：越来越多的证据表明，在慢性肾脏疾病的早期阶段，诸如严格的血压控制，血管紧张素转换酶（ACE）抑制剂（ACE）抑制剂（ACE）抑制剂（ARB）等治疗干预措施有效地减慢了慢性肾脏病的进展。但是，人们普遍认为，在美国，CKD被“未被诊断”和“治疗不足”，导致预防机会丢失。很少有研究试图评估与CKD识别不良和治疗相关的因素。在这项研究中，我们将向来自AMA主文件的初级保健医生的随机样本发送问卷。这些问卷将关注医生能够识别不同年龄段的男性和女性CKD的能力，他们对血压目标的态度以及CKD患者的ACE抑制剂和ARB的使用以及在CKD中对心血管疾病风险的信念。然后，我们将分析数据以得出医师特征，即毕业年。与更好地识别CKD和对管理CKD患者符合当前文献和指南的患者的态度有关的能力。